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In Our Own Backyard
Jeanne Zukas, DO; Suzanne Templer, DO
Lehigh Valley Health Network, Allentown, Pennsylvania

Transmission
• Vector: Ixodes scapularis tick
• Incubation period:  1 - 9 weeks
• Peak prevalence: May to October
• Location: New England/ northeastern
United States

Diagnosis
• PCR
• Blood smear visualization of intra-erythrocytic inclusions
• Antibody serology

Treatment
• Mild to moderate disease - Atovaquone 750 mg orally twice a day &
Azithromycin on day 1 give 500-1000 mg orally; on subsequent days,
give a total daily dose in the range of 250-1000 mg
• Severe disease - Clindamycin 600 mg orally 3 times a day & Quinine
650 mg orally 3 times a day
- R
 BC exchange transfusion- indicated when the level of parasitemia
is greater than 10%, renal or hepatic dysfunction occur, substantial
hemolysis is present, or the patient experiences respiratory distress.
Blood smear monitoring is performed until the level of parasitemia is
<5%.  
- Risk factors for severe disease: asplenia, immunocompromised state, &
age >50
- Mortality rate: 5% in immunocompetent patients & 21% in
immunocompromised populations

• Duration of therapy: 7-10 days

Case

Summary

A 77 year old female from eastern Pennsylvania presented with one
month of progressive fatigue, anorexia, dark colored urine, and increasing
weakness, prompting her to seek medical attention.  On presentation, the
patient had slowed mental acuity, but was appropriate.  She denied other
symptoms.  Her exam was completely non-focal, with the exception of a
tick on her right calf.
Labs revealed a new macrocytic anemia (hemoglobin 7.1 g/dl) and
thrombocytopenia (92K platelets).  CT imaging of her abdomen and pelvis
was normal with the exception of a new splenic infarct.  A peripheral
blood smear demonstrated intra-erythrocytic ringed forms.  Slides were
then sent to the State DOH and the CDC for confirmation of the diagnosis.  
The percent parasitemia was reported by the CDC as >10.  A diagnosis of
babesiosis was made.  
Treatment was initiated with Quinine and Clindamycin.  Given her
advanced age and her other lab findings, RBC exchange transfusion
was performed.  Afterwards, her mental status, weakness, and appetite
improved.  Her hemoglobin improved to 10.2 g/dl; and, her repeat blood
smears showed clearance of the parasite.  Further testing revealed coinfections with Borrelia burgdorferi and Anaplasma phagocytophilum.  
She completed a full course of therapy for all three infections.  She did
experience some hypoglycemia as a result of her Quinine therapy, but this
resolved after cessation of treatment.

Signs/Symptoms
• Asymptomatic
• Mild/Moderate:
- F
 ever/chills - most common
presenting symptoms
- Nausea/ vomiting
- Fatigue
- Headaches
- Anorexia
- Myalgias/ arthralgias
- Lab findings: Anemia/
thrombocytopenia

• Severe
- A
 cute respiratory failure/ pulmonary
edema/ ARDS
- Change in mental state
- Sepsis/ DIC
- Acute renal failure
- Acuate hepatic failure
- Anorexia
- Myalgias/ arthralgias
- Lab findings: marked
thrombocytopenia

• Physical exam findings:
hepatomegaly/ splenomegaly/
jaundice

Babesiosis is an emerging infectious disease,
newly reportable to the CDC this year. No
rapid test for exposure to B. microti exists,
and blood transfusion related infections have
occurred.
Cases of babesiosis are on the rise in Eastern
Pennsylvania.  Our patient presented with a
rare case of co-infection with B. microti, B.
burgdorferi and A. phagocytophilum. In patients living in tick infested
areas presenting with fevers, new onset of macrocytic anemia, and/or
history of tick exposure, this diagnosis should be strongly considered.  
Prompt recognition can prevent complications of this potentially fatal
infection.
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